Medicaid was accepted by less than half of allergists in 13 states. Women were more likely to have a positive oral challenge compared with men. More than 60% of patients reported discontinuing treatment due to social factors. The panel discusses how health care providers can be allies in addressing disparities in allergy care. Dupilumab is a monoclonal antibody approved to treat atopic dermatitis in adolescents and children. Advocacy includes directly supporting patients and influencing broader health policies at the community and national levels. The risk of seizure was higher in children aged 6 to 24 months. Panelists discuss how health care providers can lead the conversation to improve food allergy safety in communities. Most respondents agreed a patient-centered definition would improve communication with providers. The panelists discuss how health care providers can get involved in creating allergy action plans and kits. The global prevalence of pediatric atopic dermatitis increased from 1990 to 2019. Anxiety regarding accidental allergen exposure may create stress for patients and affect their quality of life. Disparities in health education on safe exposure to allergenic foods may influence food allergy incidence. Education on early introduction of allergenic foods is crucial to prevent food allergies. Psoriasis was linked to greater odds of asthma and eczema. Panelists discuss how physicians and allergists can distinguish between food intolerance and anaphylaxis. Iron deficiency anemia (IDA) may be associated with an increased risk of asthma Care such as oral food challenges, a key diagnostic tool, may also be inaccessible without a local allergist. Dr. Powell highlights how socioeconomic status and race influence the prevalence and management of food allergies. Neffy is the first noninjectable epinephrine product approved for treating anaphylaxis.